CNTBConnect Biopharma Holdings Limited

2.360USDMkt Cap: 148.62M $P/E:

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for…

Key Statistics

Company
Market Cap148.62M $
Enterprise Value117.73M $
Revenue (TTM)2.95M $
Gross Profit2.95M $
Net Income (TTM)-55.48M $
Revenue/Share0.0510 USD
Last Price2.360 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees64
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-3.16
PEG
EV/EBITDA-1.69
EV/Revenue39.87
P/S50.33
P/B5.53
EPS (TTM)-1.19
EPS (Forward)-0.75
52W Range
2.21094% of range2.370
52W High2.370 USD
52W Low2.210 USD
Profitability
Gross Margin100.00%
Oper. Margin-635.98%
EBITDA Margin0.00%
Profit Margin-86687.50%
ROE-132.16%
ROA-98.94%
Growth
Revenue Growth5666.70%
Earnings Growth
Cash Flow & Leverage
Operating CF-51.21M $
CapEx (TTM)434.00K $
FCF Margin-1175.51%
FCF Yield-23.36%
Net Debt-30.89M $
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity0.02
Current Ratio2.37
Quick Ratio2.11
Book Value/Sh0.4270 USD
Cash/Share0.5000 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.250 USD
Upside (mean)+207.2%
Target Range4.000 USD10.00 USD
$4.000+207.2% to mean$10.00
# Analysts8
Ownership
Shares Out.62.97M
Float21.07M
Insiders29.68%
Institutions56.13%
Short Interest
Short Ratio4.2d
Short % Float4.64%
Short % Out.3.27%
Shares Short2.06M
Short (prev mo.)1.33M
Technical
SMA 502.237 (+5.5%)
SMA 2002.449 (-3.6%)
Beta
S&P 52W Chg19.18%
Avg Vol (30d)438.00K
Avg Vol (10d)459.28K
Technical Indicators
RSI (14)53.3
MACD0.0517
MACD Signal0.0346
MACD Hist.+0.0171
BB Upper2.602 USD
BB Middle2.239 USD
BB Lower1.876 USD
BB Width32.44%
ATR (14)0.1746 USD
Vol Ratio (20d)1.19x